2024 annual financial data
BriaCell Therapeutics 2024 Operating margin
BriaCell Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -33,330,076 USD and net income was -4,791,466 USD.
Operating cash flow was -24,126,128 USD.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -33,330,076 USD
- Net income
- -4,791,466 USD
- Operating cash flow
- -24,126,128 USD